A patient suffering from AIDS is on Zidovudine, Lamivudine, Indinavir therapy, He develops pulmonary tuberculosis for which treatment is staed. Which of the following should be avoided in him
Refer KDT 6/e p 741 *Rifamipicin is a powerful enzyme inducer. It increases the metabolism of protease inhibitors and thus decreases the efficacy of anti retroviral therapy *another drug, rifabutin is devoid of these interactions and is the preferred agent for treatment of mycobacterial infections in patients
INH
Ethambutol
Pyrazinamide
Rifampicin
Chemotherapy